Clinical Hold Averted

A client received a potential clinical hold letter from FDA that required the company to perform a newly approved test. They were ready to concede, but Dr. Gorelick convinced them to challenge the Agency’s demand. He developed a briefing book and submitted a request for a type A meeting with the BB. A telephonic meeting was held 30 days later, and the FDA agreed that the company could continue without performing the test.